Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan‒tadalafil in pulmonary arterial hypertension-Reference-Cited by-同舟云学术

Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan‒tadalafil in pulmonary arterial hypertension

Published:2020-12 Issue:12 Volume:39 Page:1389-1397
ISSN:1053-2498
Container-title:The Journal of Heart and Lung Transplantation
language:en
Short-container-title:The Journal of Heart and Lung Transplantation

Author:

D'Alto Michele,Badagliacca Roberto,Lo Giudice Francesco,Argiento Paola,Casu Gavino,Corda Marco,Correale Michele,Ghio Stefano,Greco Alessandra,Lattanzio Mariangela,Mercurio Valentina,Paciocco Giuseppe,Papa Silvia,Prediletto Renato,Romeo Emanuele,Russo Maria Giovanna,Tayar Alessandro,Vitulo Patrizio,Vizza Carmine Dario,Golino Paolo,Naeije Robert

Publisher

Elsevier BV

Subject

Transplantation,Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference28 articles.

1. Risk stratification and medical therapy of pulmonary arterial hypertension;Galiè;Eur Respir J,2019

2. Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension;Galiè;N Engl J Med,2015

3. Point: should initial combination therapy be the standard of care in pulmonary arterial hypertension? Yes;Humbert;Chest,2019

4. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL);Benza;Circulation,2010

5. The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension;Benza;Chest,2012

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensus;Vascular Pharmacology;2024-09

2. Risk stratification and treatment goals in pulmonary arterial hypertension;European Respiratory Journal;2024-08-29

3. Relevance of Echocardiography-derived Phenotyping in Patients with Pulmonary Arterial Hypertension Treated with Initial Oral Combination Therapy: An Italian Pulmonary Hypertension Network (iPHNET) Study;American Journal of Respiratory and Critical Care Medicine;2024-08-01

4. Prognostic Value of Serial Risk Stratification in Adult and Pediatric Pulmonary Arterial Hypertension: A Systematic Review;Journal of the American Heart Association;2024-07-02

5. Fixed-dose combination therapy in pulmonary arterial hypertension: Pros & cons;International Journal of Cardiology;2024-07